esorubicin has been researched along with Acute Myelogenous Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dutcher, JP; Link, B; Riggs, CE; Strauman, JJ; Wiernik, PH | 1 |
Allen, SL; Budman, DR; Chan, K; Kreis, W; Rottach, C; Schulman, P; Vinciguerra, V; Weiselberg, L | 1 |
Löwenberg, B; Schölzel, C; van Putten, W | 1 |
3 other study(ies) available for esorubicin and Acute Myelogenous Leukemia
Article | Year |
---|---|
A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemia.
Topics: Adult; Aged; Blast Crisis; Blood Cell Count; Bone Marrow; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate; Middle Aged; Mucous Membrane; Remission Induction | 1989 |
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.
Topics: Doxorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate | 1988 |
A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.
Topics: Adult; Antineoplastic Agents; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Tumor Stem Cell Assay | 1986 |